Abstract | OBJECTIVES: The nitric oxide/cyclic guanosine monophosphate ( GMP)/cyclic GMP-dependent protein kinase type I (cGKI) pathway has been extensively investigated in the spontaneously hypertensive rat (SHR) as a possible pathogenetic factor. Therefore, we investigated the role of nitric oxide/cGKI on intracellular calcium dynamics ([Ca2+]i) of aortic smooth muscle cells isolated from control normotensive Wistar Kyoto rats (WKY) and SHR. METHODS: Rat aortic smooth muscle cells (RASMCs) were obtained from 12 to 16-week-old WKY and SHR. [Ca2+]i dynamics were monitored by imaging analysis of fura-2-loaded RASMCs. cGKI mRNA and cGKI protein expression were evaluated by reverse transcription-PCR and western blot. Plasmids codifying for enhanced green fluorescent protein (EGFP) or cGKIalpha-EGFP were transfected on SHR RASMCs. RESULTS:
Angiotensin II similarly increased [Ca2+]i in WKY and SHR RASMCs. In WKY RASMCs, S-nitroso-N-acetyl-DL- penicillamine (SNAP, 1-100 micromol/l) reduced the decay time of angiotensin II-induced [Ca2+]i transient. On the contrary, in SHR cells, SNAP was ineffective. Dibutyryl cyclic GMP (1-100 nmol/l), a membrane-permeable cyclic GMP analogue, behaved similarly to SNAP. In naive SHR RASMCs, cGKI mRNA and cGKI protein were low or absent. After transfection of a plasmid encoding for cGKIalpha-EGFP, the [Ca2+]i dynamic of SHR-transfected cells regained sensitivity to the nitric oxide/ cyclic GMP pathway. CONCLUSION: The low expression of cGKI determines the lack of nitric oxide/ cyclic GMP-dependent regulation on [Ca2+]i transient in SHR RASMCs. This alteration may contribute to the development of hypertension and explain suboptimal responses to nitroglycerin and other nitric oxide-releasing molecules in patients.
|
Authors | Lorenzo Di Cesare Mannelli, Silvia Nistri, Luca Mazzetti, Daniele Bani, Robert Feil, Paola Failli |
Journal | Journal of hypertension
(J Hypertens)
Vol. 27
Issue 6
Pg. 1258-67
(Jun 2009)
ISSN: 1473-5598 [Electronic] Netherlands |
PMID | 19307986
(Publication Type: Journal Article)
|
Chemical References |
- DNA Primers
- Nitric Oxide Donors
- RNA, Messenger
- Recombinant Proteins
- enhanced green fluorescent protein
- Angiotensin II
- Green Fluorescent Proteins
- Nitric Oxide
- Dibutyryl Cyclic GMP
- S-Nitroso-N-Acetylpenicillamine
- Cyclic GMP-Dependent Protein Kinase Type I
- Cyclic GMP-Dependent Protein Kinases
|
Topics |
- Angiotensin II
(pharmacology)
- Animals
- Aorta, Thoracic
(metabolism)
- Base Sequence
- Calcium Signaling
(drug effects, physiology)
- Cyclic GMP-Dependent Protein Kinase Type I
- Cyclic GMP-Dependent Protein Kinases
(genetics, metabolism)
- DNA Primers
(genetics)
- Dibutyryl Cyclic GMP
(pharmacology)
- Green Fluorescent Proteins
(genetics)
- Hypertension
(genetics, metabolism)
- In Vitro Techniques
- Myocytes, Smooth Muscle
(drug effects, metabolism)
- Nitric Oxide
(metabolism)
- Nitric Oxide Donors
(pharmacology)
- RNA, Messenger
(genetics, metabolism)
- Rats
- Rats, Inbred SHR
- Rats, Inbred WKY
- Recombinant Proteins
(genetics)
- S-Nitroso-N-Acetylpenicillamine
(pharmacology)
- Transfection
|